Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MEDICAMEQ Medicamen Biotech Limited Pharma · Small | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | AMBALALSA Ambalal Sarabhai Enterprises Limited Pharma · Small | ARVEE Arvee Laboratories (India) Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 19 | 15 | 45 | 21 |
| Verdict | OVERVALUED | OVERVALUED | WATCHLIST | OVERVALUED |
| Style | OVERVALUED | OVERVALUED | Financial Turnaround | OVERVALUED |
| Piotroski | 5/9 | 6/9 | 7/9 | 5/9 |
| Valuation | 4/30 | 3/30 | 17/30 | 0/30 |
| Growth | 5/25 | 2/25 | 12/25 | 11/25 |
| Quality | 0/20 | 0/20 | 2/20 | 0/20 |
| Balance Sheet | 9/15 | 6/15 | 7/15 | 11/15 |
| Cash Flow | 0/10 | 4/10 | 5/10 | 3/10 |
| Price | ₹239.75 | ₹80.24 | ₹34.3 | ₹163.57 |
| P/E | 33.30 | 55.60 | 14.20 | 69.60 |
| P/B | 1.18 | 1.47 | 1.65 | 5.21 |
| ROE | 3.95% | 2.75% | 12.40% | 7.78% |
| ROCE | 5.43% | 5.58% | 11.50% | 7.92% |
| Debt / Equity | 0.17 | 0.33 | 0.36 | 0.03 |
| FCF Yield | — | — | 1.14% | 0.22% |
| Dividend Y | 0.42% | — | — | — |
| Altman Z | 3.97 | 3.33 | 2.77 | 7.99 |
| Promoter % | 40.46% | 37.71% | 31.36% | 73.50% |
| Mkt Cap (₹Cr) | 321.00 | 221.00 | 264.00 | 176.00 |
| Graham # | ₹180.21 | ₹40.86 | ₹32.87 | ₹39.86 |
| Fair PE | 5.8 | 4.2 | 42.3 | 42.0 |
| MoS % | -483.4% | -1261.3% | +65.1% | -69.3% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMEDICAMEQ47
AAREYDRUGS125
AMBALALSA97
ARVEE96